The Tester Cartel Crack — The Week TEL Reached Across to Teradyne on Advantest's ¥20T Coronation Day

Coronation and Crack, Same Week

On June 9, Nikkei reported Advantest's (6857) market cap had crossed ¥20 trillion — the destination of a roughly 60-fold share-price climb that began with the 2011 acquisition of US-based Verigy. The same day, CEO Koichi Tsukui told the press that "AI chip evolution is only just getting started" and that the industry is moving "from a mass-production era to a complexity era" — a message that test time per die is going structurally up, and Advantest's handlers go with it.

Then, on June 8, Teradyne and Tokyo Electron (TEL, 8035) announced a co-developed AI-chip test solution, pairing Teradyne's ATE platform with TEL's wafer probing. On its face it is collaboration. In substance, it is the first serious challenge to Advantest's SoC/HBM handler monopoly — and the more arresting fact is that TEL is the partner. Inside Tokyo's equipment cluster, Advantest and TEL were, until this week, on the same side of the table.

Why TEL Switched Lanes

TEL does not make testers; Advantest does not make probers. Their footprints never crossed. But in the AI back end, the bottleneck has shifted to test time and known-good-die yield, and the company that designs the prober-tester interface owns the margin. That is Tsukui's "complexity era" by another name.

TEL CEO Toshiki Kawai's Nikkei interview this week walked through WFE outlook and HBM capex strategy but said nothing about test integration. The signal the market should read is clear: TEL has decided to take a slice of the ASIC/HBM test margin Advantest had been collecting alone — and its partner is American, not Japanese.

The Tape Has Already Split in Two

Friday June 6 set the table: US SOX -10% (worst since 2020) on a Broadcom miss, Chicago Nikkei futures closing ¥2,645 below Osaka. Monday June 8 delivered the impact — Nikkei -3,100 points intraday, -2,563 at the close, AI and semis dumped first. Tuesday morning the futures were already +1.26% on the 25-day MA (¥63,850), SPE names leading. In a single session the tape re-bought the "complexity era" story.

Shin-Etsu Chemical (4063) corroborates the rebid. A major US broker held bullish and raised PT to ¥9,520; a mid-tier domestic broker raised to ¥9,500; IFIS consensus FY3/27 recurring profit was lifted 1.8% W/W. Sell-side tone is hardening across the whole value chain, not just the testers. Strategist Tomio Sugimura's June 7 call for a Nikkei 73,000 path with Kioxia and Rohm as picks fits the same frame.

The Risks: Rare Earths and SpaceX

Two external shocks sit alongside this narrative. First, China is tightening rare-earth export controls aimed at Japan (multiple wires, June 8), with defense and semiconductors as the explicit targets. Some magnet/abrasive/photo-material lines have less than six weeks of buffer. Second, the SpaceX IPO on June 12 (~¥12T raise, ~¥283T cap) is positioned by Kabutan as a liquidity drain that will force rotation out of index-leading AI/semi names into laggards.

DDR5 16Gb spot sits at $44.0 (June 9) — the shortage narrative is in the price but not yet fully in the equity. The SIA April print ($110.5B, +11% M/M) was strong, but Japan's share slipped to 3%, a reminder that the "Japan revival" lives on the equipment and materials side, not in memory or logic.

Positioning

The central name is Advantest (6857). The ¥20T coronation and the "complexity era" declaration anchor a new PSR baseline; the Teradyne-TEL alliance will need 18–24 months to convert into share. In that window, the handler cycle gets one more leg up as HBM4 and CoWoS go to high-volume manufacturing. But carry TEL as a hedge. If the Teradyne-TEL combination books even one major N3/N2 ASIC test win, Advantest's multiple expansion stops there. Shin-Etsu (4063) is a separate trade — silicon wafer and photoresist pricing power is independent of handler alliance politics.

With the Takaichi government's growth support framed as policy tailwind (June 7 op-eds), the real Nikkei beta is no longer Toyota — it is the test / etch / materials trio. The most important line in this week's flow was not Tsukui's "complexity era." It was the press release on the next page.

Key Sources: - Advantest market cap tops ¥20T as US Verigy buyout drives 60x stock rally (Nikkei, 2026-06-09) - Teradyne and Tokyo Electron Unveil Joint Test Solution for AI Chips (Nikkei, 2026-06-08) - Advantest CEO Tsukui: AI chip evolution just accelerating, complexity era boosts tester demand (Kabutan, 2026-06-09) - Shin-Etsu Chemical: US broker stays bullish, lifts price target to ¥9,520 (Nikkei, 2026-06-08) - Nikkei plunges 2,563 pts as AI/semi stocks face selling washout (Kabutan, 2026-06-08) - plus 26 more